Publication | Closed Access

Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a TOP2A inhibitor

Temozolomide ChemotherapyHigher Topoisomerase 2MedicinePathologyCancer GenomicsMetronomic ChemotherapyCancer TreatmentOncologyRadiation OncologyCancer ResearchGbm PatientsTumor Biology